FDA expands authorization for a Johnson & Johnson drug

The FDA has expanded the market authorization for a Johnson & Johnson drug.

Published 2h1 sourceNotableupdated 2h

≈ 19sSpeed

The fact

This treatment targets a specific pathology and could benefit thousands of patients in the U.S.

The decision strengthens J&J's position in the American pharmaceutical market.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on August 25, 2026